Wallaby Medical announces CE mark and FDA clearance of the Avenir coil system
Wallaby Medical has announced CE mark approval and FDA 510(k) clearance of its differentiated embolic coil system—the Avenir coil system. The intended use for the Avenir coil system is for endovascular embolisation of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The Avenir coil system is also intended for [...]